![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Molecular Data Inc | NASDAQ:MKD | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.41 | 0.42 | 0.4639 | 0 | 01:00:00 |
| | |
Per
Convertible Note |
| |
Total
|
| ||||||
Offering Price
|
| | | $ | 1,900,000 | | | | | | 1,900,000 | | |
Proceeds, before expenses, to us
|
| | | $ | 1,850,000 | | | | | | 1,850,000 | | |
| | |
Page
|
| |||
| | | | S-1 | | | |
| | | | S-1 | | | |
| | | | S-3 | | | |
| | | | S-4 | | | |
| | | | S-8 | | | |
| | | | S-9 | | | |
| | | | S-11 | | | |
| | | | S-11 | | | |
| | | | S-12 | | | |
| | | | S-13 | | | |
| | | | S-14 | | | |
| | | | S-15 | | | |
| | | | S-15 | | | |
| | | | S-15 | | | |
| | | | S-17 | | | |
| | | | S-18 | | |
| | |
As of December, 2020
|
| |||||||||||||||||||||
|
Actual
|
| |
Pro forma
|
| ||||||||||||||||||||
|
(in thousands)
|
| |||||||||||||||||||||||
|
RMB
|
| |
US$
|
| |
RMB
|
| |
US$
|
| ||||||||||||||
Indebtedness: | | | | | | | | | | | | | | | | | | | | | | | | | |
Long term borrowing(1)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Equity: | | | | | | | | | | | | | | | | | | | | | | | | | |
Ordinary shares (US$0.00005 par value; 1,000,000,000 shares authorized)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Class A ordinary shares, (US$0.00005 par value; No
shares authorized, issued and outstanding; 334,999,682 Class A ordinary shares issued and 304,488,317 outstanding; 550,000,000 shares authorized, 343,999,682 shares issued and outstanding on a pro-forma basis;) |
| | | | 101 | | | | | | 15 | | | | | | 112 | | | | | | 17 | | |
Class B ordinary shares, (US$0.00005 par value; 54,819,733 Class B ordinary shares issued and outstanding; 54,819,733 shares issued and outstanding on a pro-forma basis)
|
| | | | 12 | | | | | | 2 | | | | | | 12 | | | | | | 2 | | |
Additional paid-in capital
|
| | | | 1,075,064 | | | | | | 164,761 | | | | | | 1,095,050 | | | | | | 167,311 | | |
Accumulated deficits
|
| | | | (1,103,056) | | | | | | (169,051) | | | | | | (1,123,054) | | | | | | (171,603) | | |
Total shareholders’ equity/(deficit)
|
| | | | (27,879) | | | | | | (4,273) | | | | | | (27,879) | | | | | | (4,273) | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 15 | | | |
| | | | | 26 | | | |
| | | | | 28 | | | |
| | | | | 30 | | | |
| | | | | 32 | | | |
| | | | | 34 | | | |
| | | | | 35 | | | |
| | | | | 36 | | | |
| | | | | 39 | | | |
| | | | | 40 | | | |
| | | | | 41 | | |
1 Year Molecular Data Chart |
1 Month Molecular Data Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions